Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants.

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH 44106, USA.
Medical & Biological Engineering (Impact Factor: 1.76). 10/2008; 46(10):1039-49. DOI: 10.1007/s11517-008-0354-7
Source: PubMed

ABSTRACT Radiofrequency ablation has emerged as a minimally invasive option for liver cancer treatment, but local tumor recurrence is common. To eliminate residual tumor cells in the ablated tumor, biodegradable polymer millirods have been designed for local drug (e.g., doxorubicin) delivery. A limitation of this method has been the extent of drug penetration into the tumor (<5 mm), especially in the peripheral tumor rim where thermal ablation is less effective. To provide drug concentration above the therapeutic level as needed throughout a large tumor, implant strategies with multiple millirods were devised using a computational model. This dynamic, 3-D mass balance model of drug distribution in tissue was used to simulate the consequences of various numbers of implants in different locations. Experimental testing of model predictions was performed in a rabbit VX2 carcinoma model. This study demonstrates the value of multiple implants to provide therapeutic drug levels in large ablated tumors.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, an adaptive robust control strategy is developed for the manipulation of drug usage and consequently the tumor volume in cancer chemotherapy. Three nonlinear mathematical cell-kill models including log-kill hypothesis, Norton-Simon hypothesis and Emax hypothesis are considered in the presence of uncertainties. The Lyapunov stability theorem is used to investigate the global stability and tracking convergence of the process response. For the first time, performance of the uncertain process is investigated and compared for three nonlinear models. In addition, the effects of treatment period, initial value of tumor volume (carrying capacity) and the uncertainty amount on dynamic system behaviour are studied. Through a comprehensive evaluation, results are presented and compared for three cell-kill models. According to the results, for a wide range of model uncertainties, the adaptive controller guarantees the robust performance. However, for a given treatment period, more variation in drug usage is required as the amount of model uncertainty increases. Moreover, for both the nominal and uncertain models, less drug usage is required as the treatment period increases. Copyright © 2014 Elsevier Ltd. All rights reserved.
    Computers in Biology and Medicine 11/2014; 56C:145-157. DOI:10.1016/j.compbiomed.2014.11.002 · 1.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: To investigate the potential of conductive interstitial thermal therapy (CITT) to inhibit recurrence and metastasis in a partially resected tumour model. Method: Fifteen New Zealand white rabbits were implanted with VX2 tumour intramuscularly in the rear thigh. Once the tumour size reached 20–25 mm in diameter, three animals were randomly selected to serve as controls, while the remaining animals were designated as the study group and treated with CITT. In the CITT group, the partially resected tumour and margins were thermally ablated. In the control group the tumour was partially resected to simulate positive margins. The animals were monitored for up to 12 weeks. At the endpoint, the animals were sacrificed, and whole-body diagnostic necropsy was conducted immediately. Results: Recurrences and metastatic lesions were observed in iliac and popliteal lymph nodes and abdomens of all control animals. In contrast, the observed rate of recurrence and metastatic lesion was 0% among CITT-treated animals, significantly less than the ≥50% null-hypothesis rate expected upon treatment failure (exact binomial P = 0.0002). Complete histopathological healing was obtained in 2 of 12 rabbits, and residual inflammation remained at the ablation site up to 12 weeks post-ablation in 10 of 12 rabbits. This pattern of necrosis and inflammatory response was not observed in any of the control rabbits. Conclusions: The CITT device effectively ablated partially resected VX2 carcinoma in a rabbit model, and inhibited recurrence and metastasis in this model. CITT evoked an inflammatory response that may be linked to the mechanism involved in reduced metastatic spread.
    International Journal of Hyperthermia 09/2009; 25(6):446-454. DOI:10.1080/02656730903013618 · 2.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Copolymers of (D,L-lactide-random-ε-caprolactone)-block-poy(ethylene glycol)-block-(D,L-lactide-random-ε-caprolactone) or PLEC were explored as materials for injectable drug delivery system. A series of six PLECs were successfully synthesized with varied D,L-lactide (LA) content (0, 10 and 20%) and molecular weight (20 and 50 kDa). All polymers were able to form depots with more than 90% encapsulation efficiency of trypan blue leading to the loading density as high as 27% w/w. The variation of trypan blue loading, LA content and molecular weight were found to have profound effects on trypan blue release profiles. Even though, GPC and SEM confirmed the higher degradation of PLEC chains, trypan blue release rate and burst release was greater as the content of hydrophilic moiety, i.e. LA, was decreased. This was primarily due to the smooth and dense surface and cross-section of PLEC depots. The results from this study suggest a possible application of these depots as injectable, self-solidifying drug delivery systems.
    Journal of Polymer Research 03/2012; 19(3). DOI:10.1007/s10965-012-9834-4 · 1.90 Impact Factor